Appendix 2—table 24. Statin Cohort (All Regions), Patient Characteristics Pre/Post Match.
| All Observations by Statin Use: Unmatched | All Observations by Statin Use: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Statin Non-users | Statin Users | p-value | All | Statin Non-users | Statin Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 7,906,603 | 100.00% | 6,403,208 | 81.00% | 1,503,395 | 19.00% | 2,872,600 | 100.00% | 1,436,300 | 50.00% | 1,436,300 | 50.00% | ||
| Age | ||||||||||||||
| ≤20 | 1,840,050 | 23.30% | 1,838,665 | 28.70% | 1,385 | 0.10% | <0.001 | 2,772 | 0.10% | 1,387 | 0.10% | 1,385 | 0.10% | 0.11 |
| 21-40 | 1,446,999 | 18.30% | 1,402,606 | 21.90% | 44,393 | 3.00% | 88,760 | 3.10% | 44,371 | 3.10% | 44,389 | 3.10% | ||
| 41-50 | 925,309 | 11.70% | 789,385 | 12.30% | 135,924 | 9.00% | 271,615 | 9.50% | 135,748 | 9.50% | 135,867 | 9.50% | ||
| 51-60 | 1,250,190 | 15.80% | 888,510 | 13.90% | 361,680 | 24.10% | 710,481 | 24.70% | 354,449 | 24.70% | 356,032 | 24.80% | ||
| 61-70 | 1,181,261 | 14.90% | 728,702 | 11.40% | 452,559 | 30.10% | 857,269 | 29.80% | 428,326 | 29.80% | 428,943 | 29.90% | ||
| 71-80 | 783,775 | 9.90% | 452,267 | 7.10% | 331,508 | 22.10% | 605,360 | 21.10% | 303,279 | 21.10% | 302,081 | 21.00% | ||
| ≥81 | 479,019 | 6.10% | 303,073 | 4.70% | 175,946 | 11.70% | 336,343 | 11.70% | 168,740 | 11.70% | 167,603 | 11.70% | ||
| Gender | ||||||||||||||
| Female | 4,670,960 | 59.10% | 3,785,061 | 59.10% | 885,899 | 58.90% | <0.001 | 1,682,354 | 58.60% | 839,207 | 58.40% | 843,147 | 58.70% | <0.001 |
| Male | 3,235,643 | 40.90% | 2,618,147 | 40.90% | 617,496 | 41.10% | 1,190,246 | 41.40% | 597,093 | 41.60% | 593,153 | 41.30% | ||
| Region | ||||||||||||||
| Midwest | 1,467,802 | 18.60% | 1,188,569 | 18.60% | 279,233 | 18.60% | <0.001 | 542,638 | 18.90% | 271,319 | 18.90% | 271,319 | 18.90% | 1 |
| Northeast | 2,152,560 | 27.20% | 1,706,021 | 26.60% | 446,539 | 29.70% | 847,868 | 29.50% | 423,934 | 29.50% | 423,934 | 29.50% | ||
| South | 3,042,604 | 38.50% | 2,490,630 | 38.90% | 551,974 | 36.70% | 1,046,224 | 36.40% | 523,112 | 36.40% | 523,112 | 36.40% | ||
| West | 1,243,637 | 15.70% | 1,017,988 | 15.90% | 225,649 | 15.00% | 435,870 | 15.20% | 217,935 | 15.20% | 217,935 | 15.20% | ||
| Insurance | ||||||||||||||
| Commercial | 3,938,603 | 49.80% | 3,350,332 | 52.30% | 588,271 | 39.10% | <0.001 | 1,175,472 | 40.90% | 587,847 | 40.90% | 587,625 | 40.90% | 0.34 |
| Dual | 156,497 | 2.00% | 73,532 | 1.10% | 82,965 | 5.50% | 110,207 | 3.80% | 54,851 | 3.80% | 55,356 | 3.90% | ||
| Medicaid | 2,594,500 | 32.80% | 2,254,531 | 35.20% | 339,969 | 22.60% | 641,345 | 22.30% | 320,434 | 22.30% | 320,911 | 22.30% | ||
| Medicare | 1,217,003 | 15.40% | 724,813 | 11.30% | 492,190 | 32.70% | 945,576 | 32.90% | 473,168 | 32.90% | 472,408 | 32.90% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 4,283,697 | 54.20% | 3,773,784 | 58.90% | 509,913 | 33.90% | <0.001 | 1,016,313 | 35.40% | 508,587 | 35.40% | 507,726 | 35.30% | 0.29 |
| Yes | 3,622,906 | 45.80% | 2,629,424 | 41.10% | 993,482 | 66.10% | 1,856,287 | 64.60% | 927,713 | 64.60% | 928,574 | 64.70% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.62 | 1.38 | 0.49 | 1.23 | 1.15 | 1.79 | <0.001 | 1.11 | 1.77 | 1.12 | 1.79 | 1.11 | 1.75 | <0.001 |
CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.